DNA promoter methylation as a diagnostic and therapeutic biomarker in gallbladder cancer. - Wikidata - wikimedia - TriplyDB

DNA promoter methylation as a diagnostic and therapeutic biomarker in gallbladder cancer.

DNA promoter methylation as a diagnostic and therapeutic biomarker in gallbladder cancer.

http://www.wikidata.org/entity/Q36300261

about

The Role of Natural Polyphenols in the Prevention and Treatment of Cervical Cancer-An Overview Dietary phytochemicals and cancer chemoprevention: a review of the clinical evidence Nomograms for predicting the prognostic value of serological tumor biomarkers in colorectal cancer patients after radical resection A novel method for identification and quantification of consistently differentially methylated regions Gallbladder cancer epidemiology, pathogenesis and molecular genetics: Recent update.Global and gene-specific DNA methylation pattern discriminates cholecystitis from gallbladder cancer patients in Chile.Genome-wide methylation profiling of the different stages of hepatitis B virus-related hepatocellular carcinoma development in plasma cell-free DNA reveals potential biomarkers for early detection and high-risk monitoring of hepatocellular carcinoma Whole-exome tumor sequencing study in biliary cancer patients with a response to MEK inhibitors.Epigenetic changes in carcinogenesis of gallbladder Promoter hypermethylation of SHOX2 and SEPT9 is a potential biomarker for minimally invasive diagnosis in adenocarcinomas of the biliary tract.Combined detection tumor markers for diagnosis and prognosis of gallbladder cancer.

P2860

Q26739983-1A15982E-8D82-4EB1-9022-53587ED2CFF6 Q26745552-F7ED676B-7D86-4A48-A1F6-8A814E63F122 Q33572453-880F5A55-F88F-4BE3-90CA-1A0160C62E2B Q33599244-129B1E07-0C76-4411-8DB5-140A2AAE1E3E Q33805874-C282365A-19DC-41CD-B43C-309861DE617F Q35096197-18C9A27B-2C75-44BC-87EF-BC635B7D2D76 Q35339140-4AFD18E8-4C05-4D1A-874A-0F5015FECE1C Q36905641-6D25997E-C1BA-4A61-8923-06665931E5D6 Q37471592-2780DC00-A11B-4C2E-9EB8-8E65D8B98697 Q37497846-524F1DA4-53CA-4FE8-AD2E-86478FC945AB Q37697593-8A2432B1-C933-415D-A745-248E49C8A56B

P2860

DNA promoter methylation as a diagnostic and therapeutic biomarker in gallbladder cancer.

http://www.wikidata.org/entity/Q36300261

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

DNA promoter methylation as a diagnostic and therapeutic biomarker in gallbladder cancer.

@ast

DNA promoter methylation as a diagnostic and therapeutic biomarker in gallbladder cancer.

@en

type

label

DNA promoter methylation as a diagnostic and therapeutic biomarker in gallbladder cancer.

@ast

DNA promoter methylation as a diagnostic and therapeutic biomarker in gallbladder cancer.

@en

prefLabel

DNA promoter methylation as a diagnostic and therapeutic biomarker in gallbladder cancer.

@ast

DNA promoter methylation as a diagnostic and therapeutic biomarker in gallbladder cancer.

@en

P1433

Q36300261-F028D89C-AC58-4EAF-8F74-158D3D264586

P1476

Q36300261-A54021FE-A984-4F5B-A168-8C9E5985E16D

P2093

Q36300261-810E2EE0-E645-4EFD-986A-26A10D275A2A

Q36300261-97BA6429-CBED-41D3-8406-5DAD1A4B7E2A

Q36300261-DB56FA37-FF26-45AB-88D1-18B9541B5CD8

Q36300261-FEBC822B-9AD7-4275-80E5-734C942982A5

P2860

Q36300261-01662280-3F65-4E17-861A-CC6986283766

Q36300261-01E98F7E-0CF4-4371-9DA4-475B25BD117C

Q36300261-021129A0-30E5-445E-934C-E86139FFB780

Q36300261-02C66365-26CE-4820-9AAD-8B7D9273D6E9

Q36300261-04503F9A-57F9-4624-A58E-6D3E43F834D5

Q36300261-08636608-10D2-4E82-8E89-1E59D1A8FE39

Q36300261-0B659B46-6446-4171-AF71-7C868C8D0926

Q36300261-0E99C6FE-E060-4FEA-8302-09E12126F49C

Q36300261-0FC6BD66-0DDD-4636-B6BA-E5BE784F2451

Q36300261-148E76DE-5003-4992-9A18-294768A7834B

P2888

Q36300261-C41CBD78-FA82-4297-9A71-9D8A645C4724

P304

Q36300261-B39EA208-1206-4E34-892D-C0F27F12A887

P31

Q36300261-B99D3DC5-34F3-420B-ADD7-64C0BF94E5D3

P356

Q36300261-DA0E2945-07BE-4477-AF20-6167AB25EE24

P433

Q36300261-B609154C-9431-4745-8B14-261D1F820E59

P478

Q36300261-5A70F4BA-42A8-4EE1-B12B-D693B23B2F2B

P577

Q36300261-CF692F11-173D-4659-AA51-45F1F403128D

P5875

Q36300261-3B854EEB-E4D3-4315-B478-696393A07951

P6179

Q36300261-D19B221D-D84B-406E-A343-97084C3DC1F9

P698

Q36300261-DD1B52D3-F877-45F8-86F9-73CB6CB64F02

P921

Q36300261-CC387142-75D3-4D08-B799-0A1CD06C60F4

P932

Q36300261-C902A2DE-9E33-4584-94B9-07AA6416373A

P356

P1433

Clinical epigenetics

P1476

DNA promoter methylation as a diagnostic and therapeutic biomarker in gallbladder cancer.

@en

P2093

Juan Carlos Roa

http://www.w3.org/2001/XMLSchema#string

Oscar Tapia

http://www.w3.org/2001/XMLSchema#string

Pablo Letelier

http://www.w3.org/2001/XMLSchema#string

Priscilla Brebi

http://www.w3.org/2001/XMLSchema#string

P2860

The tumor-suppressor function of E-cadherin

Epidemiology of gallbladder disease: cholelithiasis and cancer

Reprimo, a new candidate mediator of the p53-mediated cell cycle arrest at the G2 phase

Genetic and epigenetic alterations of DLC-1 gene in hepatocellular carcinoma

Detection of bladder cancer in urine by a tumor suppressor gene hypermethylation panel

Role of the p16 tumor suppressor gene in cancer

Reprimo as a potential biomarker for early detection in gastric cancer

Aberrant methylation of Reprimo in human malignancies

Role of ubiquitin carboxy terminal hydrolase-L1 in neural cell apoptosis induced by ischemic retinal injury in vivo

Epigenetics in cancer

P2888

P304

11

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1868-7083-4-11

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2012-07-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

229089742

http://www.w3.org/2001/XMLSchema#string

P6179

1001775329

http://www.w3.org/2001/XMLSchema#string

P698

22794276

http://www.w3.org/2001/XMLSchema#string

P921

P932

3465181

http://www.w3.org/2001/XMLSchema#string